TrademarkDir
SIRTEX
LIVE

Serial Number

79109037

Owner

Sirtex Medical Limited

Attorney

Gwenn Roos

Filing Date

Oct 24, 2011

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

SIRTEX Trademark

Serial Number: 79109037 • Registration: 4252171

SIRTEX is a trademark filed by Sirtex Medical Limited on October 24, 2011. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Sirtex Medical Limited (2 trademarks)

Level 33
NORTH SYDNEY NSW 2060 , AU

Entity Type: 03

Trademark Details

Filing Date

October 24, 2011

Registration Date

December 4, 2012

Published for Opposition

September 18, 2012

Goods & Services

Pharmaceutical preparations for the treatment of cancer; biological preparations for medical and veterinary purposes, namely, for the treatment of cancer; capsules and particles in the nature of radio-isotopes, radionuclides, chemotherapeutic agents and magnetic materials for medical and pharmaceutical purposes for the treatment of cancer; chemical preparations for medical and pharmaceutical purposes for the treatment of cancer; chemical preparations for veterinary purposes for the treatment of cancer; drugs for medical purposes for the treatment of cancer; microcapsules for the treatment of cancer; microscopic particles in the nature of radio-isotopes, radionuclides, chemotherapeutic agents and magnetic materials containing radioactive material for medical therapeutic use for the treatment of cancer; microcapsules containing pharmaceutical, veterinary or medical preparations for the treatment of cancer; microcapsules and microparticles in the nature of radio-isotopes, radionuclides, chemotherapeutic agents and magnetic materials adapted to selectively deliver material, including radioactive materials, chemical agents and heat, to a target site such as a cell or organ for the treatment of cancer; microscopic particles in the nature of radio-isotopes, radionuclides, chemotherapeutic agents and magnetic materials and microcapsules for the treatment of cancer; microscopic particles in the nature of radio-isotopes, radionuclides, chemotherapeutic agents and magnetic materials adapted to selectively deliver material, including radioactive materials, chemical agents and heat, to a target site such as a cell or organ for the treatment of cancer

Medical research; scientific research for medical purposes; research and development of medical and veterinary products for medical and veterinary purposes, including pharmaceuticals, microcapsules, microparticles, radioactive materials, chemical agents and preparations, cancer treatments and treatments for diseased cells; medical and scientific research relating to molecular sciences, pharmaceuticals, drugs, chemicals and biotechnology

Filing History

LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Feb 18, 2025 LIMN
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
Aug 31, 2024 RHRD
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jun 15, 2022 NA71
REGISTERED-SEC.71 ACCEPTED
Jun 15, 2022 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 31, 2022 APRE
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
May 9, 2022 LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
May 9, 2022 LIMN
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
Apr 2, 2022 RHRD
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
Apr 2, 2022 RHRD
TEAS SECTION 71 RECEIVED
Dec 5, 2021 ES71
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Dec 4, 2021 REM4
INTERNATIONAL REGISTRATION RENEWED
Nov 11, 2021 RNWL
NEW REPRESENTATIVE AT IB RECEIVED
Apr 9, 2021 NREP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 27, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 27, 2019 REAP
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Jan 30, 2019 LIMN
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
Jan 24, 2019 RHRD
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Apr 24, 2018 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Apr 24, 2018 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 24, 2018 APRE
TEAS SECTION 71 & 15 RECEIVED
Apr 3, 2018 ES75
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 25, 2013 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 6, 2013 FICS
FINAL DISPOSITION PROCESSED
Mar 6, 2013 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 4, 2013 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 4, 2012 R.PR
NOTIFICATION PROCESSED BY IB
Oct 16, 2012 GPNX
PUBLISHED FOR OPPOSITION
Sep 18, 2012 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 29, 2012 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 29, 2012 OP2R
NOTICE OF PUBLICATION
Aug 29, 2012 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 14, 2012 PREV
EXAMINERS AMENDMENT MAILED
Aug 13, 2012 CNEA
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 13, 2012 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 13, 2012 XAEC
EXAMINERS AMENDMENT -WRITTEN
Aug 13, 2012 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 2, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 2, 2012 CRFA
ASSIGNED TO LIE
Jul 20, 2012 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 18, 2012 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 17, 2012 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 17, 2012 REAP
REFUSAL PROCESSED BY IB
Mar 24, 2012 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 1, 2012 RFCS
REFUSAL PROCESSED BY MPU
Mar 1, 2012 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 29, 2012 RFCR
NON-FINAL ACTION WRITTEN
Feb 28, 2012 CNRT
APPLICATION FILING RECEIPT MAILED
Feb 28, 2012 MAFR
ASSIGNED TO EXAMINER
Feb 24, 2012 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 24, 2012 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 23, 2012 REPR

Related Trademarks

More from this Owner

SIR-SPHERES

SIR-SPHERES

SIR-SPHERES

SIR-SPHERES